Pfizer is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the stock trades at its lowest levels in 13 years.Shares are down 19% over the past ...

Despite trading near decade-low valuations, Pfizer PFE is strategically repositioning itself for substantial long-term growth through its oncology transformation, particularly via the Seagen ...

The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company executive to investigate an allegation that clinical testing related to the ...

North Carolina has pulled its economic incentive for the drug manufacturing giant Pfizer to hire hundreds of workers in the Lee County seat of Sanford. The decision Wednesday arrived three months ...

The HER2-targeted antibody-drug conjugate that Pfizer gained from its Seagen buyout has delivered positive results in a pivotal study among Chinese patients with newly diagnosed bladder cancer ...

Investing.com -- Moody’s Ratings has assigned an A2 rating to Pfizer Netherlands International Finance B.V. (PNIF BV), a fully owned subsidiary of Pfizer Inc. (NYSE:PFE) The rating is for the ...

The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company executive to investigate an allegation that clinical testing related to the ...

Lawmakers are investigating whether Pfizer waited to share results of the Covid vaccine in 2020 until after that year’s presidential election, based on new allegations that a former Pfizer ...

At Pfizer's share price at the time of this writing ($22.87), you'd need to invest roughly $132,966 to generate $10,000 in income. Putting such a steep amount in only one stock would only be ...

Looking for income? You might want to check out Pfizer (NYSE: PFE). This big drugmaker has been a favorite for income investors for years. However, its dividend is arguably more attractive than ever.

WASHINGTON, May 15 (Reuters) - U.S. lawmakers on Thursday asked Pfizer Inc (PFE.N), opens new tab for information on alleged comments by a former executive suggesting its research executives ...